The FDA has expressed optimism about a voice-based ai model related to heart failure. There are also reports of fda clearance for an ai model for a different condition, pulmonary hypertension. The relationship between these developments and other advancements in cardiology, such as the use of ai in private cardiology practices, is unclear.